Y-Intercept (HK)’s Ionis Pharmaceuticals IONS Stock Holding History

Y-Intercept (HK)’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.98M	Buy	133,924 +66,550	+99%	+$3.78M	0.13%	185
2026 Q2	$5.34M	Buy	+67,374	New	+$5.07M	0.11%	259
2025 Q3	–	Sell	-37,649	Closed	-$1.49M	–	1788
2025 Q2	$1.49M	Buy	+37,649	New	+$1.23M	0.04%	744
2025 Q1	–	Sell	-9,407	Closed	-$329K	–	1399
2024 Q4	$329K	Sell	9,407 -10,734	-53%	-$401K	0.02%	904
2024 Q3	$807K	Buy	+20,141	New	+$937K	0.05%	537
2023 Q4	–	Sell	-8,803	Closed	-$399K	–	1428
2023 Q3	$399K	Buy	+8,803	New	+$363K	0.04%	648
2022 Q2	–	Sell	-10,689	Closed	-$396K	–	1019
2022 Q1	$396K	Buy	+10,689	New	+$350K	0.09%	356

Other funds holding IONS

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Nicollet Investment Management Minneapolis, Minnesota $336M AUM 22.24% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Cypress Capital Franklin, Tennessee $377M AUM 11.3% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Frank Rimerman Advisors Palo Alto, California $1.81B AUM 32.96% 1-Year Est. Return

Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return

Y-Intercept (HK)'s IONS Position: Q3 2026 in Review

Y-Intercept (HK) increased its Ionis Pharmaceuticals (IONS) stake by 99% in Q3 2026, buying an estimated $3.78M and bringing the position to 133,924 shares worth $5.98M. The position accounts for 0.13% of the portfolio, ranked #185.

Y-Intercept (HK) first reported a position in IONS in Q1 2022 and has held it in 7 quarters since. 46 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

Y-Intercept (HK) held 133,924 shares of Ionis Pharmaceuticals worth $5.98M as of Q3 2026.
Y-Intercept (HK) bought 66,550 Ionis Pharmaceuticals shares in Q3 2026, an estimated $3.78M.
Ionis Pharmaceuticals made up 0.13% of Y-Intercept (HK)'s portfolio in Q3 2026, its #185 holding.
Y-Intercept (HK) first reported a position in Ionis Pharmaceuticals in Q1 2022 and has held it in 7 quarters since.
46 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.